A recent JAMA Network Open study indicates that gender-affirming hormone therapy (GAHT) positively affects the mental health of transgender, nonbinary, and gender-diverse individuals, providing long-term benefits. This research counters widespread attacks on gender-affirming care, particularly under legislation that undermines the recognition and rights of these groups. The study analyzed data from 3,592 adult patients from two diverse community health centers, revealing that those receiving GAHT had a 15% lower risk of moderate-to-severe depression symptoms, highlighting the therapy's importance in addressing mental health disparities within this population.
"In the US, transgender, nonbinary, and gender diverse (TGD) adults have high rates of depression. Gender-affirming hormone therapy (GAHT) is associated with improved mental health outcomes..."
"Studies on this issue often rely on samples from specialized gender clinics... and do not consider the context of other TGD health disparities, such as high HIV burden."
"Those who were prescribed hormone therapy had a 15 percent lower risk of reporting moderate-to-severe depression symptoms throughout follow-up..."
Collection
[
|
...
]